Home NDC 50090-3415-0 Cholestyramine
Product NDC 50090-3415
Requested package NDC 50090-3415-0
11-digit product format 500903415
Labeler code 50090
Product ID 50090-3415_8294e797-9a67-44a8-a0e2-11fdceb677a9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cholestyramine
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler A-S Medication Solutions
Application ANDA077204
Marketing category ANDA
Marketing start 2005-09-15
Marketing end 0000-00-00
Substance CHOLESTYRAMINE
Active strength 4 g/9g
Pharmacologic classes Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077204-001 CHOLESTYRAMINE CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 A077204-002 CHOLESTYRAMINE CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A077204-001 CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A077204-002 CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-3415-0 Cholestyramine 60 in 1 CARTON POWDER, FOR SUSPENSION 60 1 50090-3415-0 Cholestyramine 9 g in 1 PACKET POWDER, FOR SUSPENSION 9 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-3415 CHOLESTYRAMINE POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS] 1 Legacy NDC, 2 package rows 20210303_543797f2-6721-436d-8de3-60822ff825a4.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-3415-0 50090341500 60 PACKET in 1 CARTON (50090-3415-0) > 9 g in 1 PACKET 60 packet 2018-03-26 0000-00-00 No No Current